Understanding Menopause Hormone Therapy

What Is Menopause Hormone Therapy (MHT)?

Menopause hormone therapy replaces the hormones your body makes less of during perimenopause and menopause. The most common approach uses estrogen (to relieve symptoms) and, if you still have your uterus, a progestogen (to protect the lining of your uterus). MHT is the most effective treatment available for menopausal symptoms and is safe for most healthy women who start it close to menopause.

Benefits of Menopause Hormone Therapy

Relief of Vasomotor Symptoms (Hot Flashes and Night Sweats)

MHT is the gold standard for treating hot flashes and night sweats. Most women experience a significant reduction — studies show a 50–75% decrease in frequency and severity. Improved sleep and daily functioning often follow.

Bone Health

Estrogen prevents bone loss and reduces the risk of fractures — including hip, spine, and other fractures — by approximately 25–35%. This benefit is especially important for women at risk for osteoporosis.

Genitourinary Syndrome of Menopause (GSM)

Vaginal dryness, painful intercourse, urinary urgency, and recurrent urinary tract infections are common after menopause. MHT — especially low-dose vaginal estrogen — is highly effective for these symptoms. Vaginal estrogen can be used even by many women who cannot take systemic (whole-body) hormone therapy.

Cardiovascular Health

When started within 10 years of menopause or before age 60, MHT may have favorable effects on the cardiovascular system, including improved blood vessel function and cholesterol profiles. It is not prescribed specifically to prevent heart disease, but the "timing hypothesis" suggests that early initiation will offer some cardiovascular protection.

Brain Health and Mood

Estrogen supports brain function and may help with the "brain fog," difficulty concentrating, and mood changes that many women experience during the menopause transition. MHT can improve mood, reduce irritability, and help with sleep — all of which support cognitive well-being. However, MHT is not recommended to prevent or treat dementia.

Diabetes Prevention

Clinical trials have shown that MHT reduces the risk of developing type 2 diabetes, likely through improved insulin sensitivity.

Lipid Levels

Estrogen therapy generally improves cholesterol profiles by raising HDL ("good" cholesterol) and lowering LDL ("bad" cholesterol). Transdermal estrogen has a more neutral effect on triglycerides compared with oral estrogen, which can raise them.

Skin Health

Estrogen helps maintain skin thickness, collagen content, elasticity, and hydration. Women on MHT often notice improvements in skin dryness, fine wrinkling, and overall skin quality. These benefits are most noticeable in sun-protected skin.

Transdermal vs. Oral Estradiol: What's the Difference?

Transdermal estradiol (patches, gels, sprays) is absorbed through the skin and goes directly into the bloodstream, bypassing the liver.

- Lower risk of blood clots (venous thromboembolism) and stroke compared with oral estrogen

- Does not raise triglycerides — preferred if you have high triglycerides

- Preferred for women with risk factors for blood clots, liver disease, migraines with aura, or high blood pressure

- Generally considered the safer route of administration

Oral estradiol  passes through the liver first, which can increase clotting factors and triglycerides.

- Still safe for many healthy women

- May be preferred for convenience or cost

*Bottom line:  Transdermal estradiol is generally preferred, especially for women with cardiovascular risk factors, obesity, or a history of blood clots.

Micronized Progesterone (Prometrium) vs. Synthetic Progestins

If you have a uterus, you need a progestogen along with estrogen to protect against uterine cancer.

Micronized progesterone (Prometrium)  is bioidentical — chemically identical to the progesterone your body naturally makes.

- Associated with a more favorable breast cancer risk profile than synthetic progestins

- May have fewer side effects (less bloating, mood changes)

- Can help with sleep (has a mild calming effect)

- Preferred by most menopause specialists

Synthetic progestins  (such as medroxyprogesterone acetate/MPA, the type used in the original WHI study):

- Effective at protecting the uterus

- Associated with a slightly higher breast cancer risk with long-term use (more than 3–5 years)

- May cause more side effects such as bloating, breast tenderness, and mood changes

*Bottom line:  Micronized progesterone is generally preferred over synthetic progestins when possible.

Understanding the Risks

Like any medication, MHT has potential risks. These risks depend on your age, health history, the type of hormones used, the route of delivery, and how long you take them.

Blood Clots (Venous Thromboembolism)

Oral estrogen slightly increases the risk of blood clots. Transdermal estrogen does not appear to carry this increased risk.

Stroke

There is a small increased risk of stroke with oral estrogen. This risk is very low in younger, healthy women (less than 1 additional case per 1,000 women per year). Transdermal estrogen at standard doses appears to carry less stroke risk.

Breast Cancer

- Estrogen-only therapy (for women without a uterus) has NOT been shown to increase breast cancer risk. In fact, the WHI showed a trend toward reduced breast cancer incidence and mortality with estrogen alone.

- Combined estrogen + progestin therapy carries a small, duration-dependent increase in breast cancer risk — roughly 1 additional case per 1,000 women per year after 5+ years of use. This risk decreases after stopping therapy.

- Using micronized progesterone instead of synthetic progestins may reduce this risk.

- To put this in perspective: the increased risk from combined MHT is similar to or less than the risk associated with drinking 1–2 glasses of wine per day, being obese, or being physically inactive.

Gallbladder Disease

Oral estrogen increases the risk of gallbladder disease. Transdermal estrogen may carry less risk.

Who Should NOT Take MHT (Contraindications)

MHT is not appropriate for everyone. It is generally not recommended for women with:

- A personal history of hormone receptor-positive breast cancer — discuss with your oncologist, as low-dose vaginal estrogen may still be an option for GSM symptoms

- Active or recent blood clots (deep vein thrombosis or pulmonary embolism)

- Active liver disease or severely impaired liver function

- Recent heart attack or stroke

- Unexplained vaginal bleeding (must be evaluated first)

- Known or suspected pregnancy

Women with these conditions have effective nonhormonal options available (see below).

Myths vs. Facts

MYTH: "Hormone therapy causes breast cancer."

FACT: Estrogen-only therapy does not increase breast cancer risk and may actually reduce it. Combined therapy carries a small increased risk only with prolonged use (5+ years), and the risk is influenced by the type of progestogen used. The absolute risk is very small.

MYTH: "The WHI study proved that all hormone therapy is dangerous."

FACT: The WHI studied older women (average age 63) using one specific formulation (oral conjugated equine estrogens + medroxyprogesterone acetate). Most participants were more than a decade past menopause. When results were analyzed by age, women aged 50–59 who started MHT close to menopause had a much more favorable risk profile, with low absolute risks and potential benefits. Today's formulations (bioidentical estradiol, transdermal delivery, micronized progesterone) are different from what was studied in the WHI. In November 2025, the FDA removed the black box warning from hormone therapy products, reflecting updated understanding of the evidence.

MYTH: "You should only take hormones for a few years."

FACT: There is no arbitrary time limit. The decision to continue MHT should be individualized based on your symptoms, health status, and ongoing risk-benefit assessment. Many women safely use MHT for years or even decades.

MYTH: "Bioidentical hormones from compounding pharmacies are safer than FDA-approved hormones."

FACT: FDA-approved bioidentical hormones (like estradiol patches and micronized progesterone) are rigorously tested for safety, purity, and effectiveness. Compounded hormones are not FDA-regulated, may have inconsistent dosing, and lack safety data. Major medical societies, including ACOG and NAMS, recommend FDA-approved products over compounded preparations.

MYTH: "Hormone therapy prevents Alzheimer's disease."

FACT: While estrogen supports brain function and may help with menopausal brain fog, there is currently no strong evidence that MHT prevents Alzheimer's disease or dementia. It should not be used for this purpose.

Beware of Misinformation Online

Social media is full of claims about menopause and hormones — many of which are not supported by evidence. A recent study found that approximately two-thirds of online claims about MHT fall outside established medical guidelines, and over 75% of those making claims had financial conflicts of interest (selling supplements, private clinics, etc.).

Common misleading claims to watch for:

- "Every woman needs hormone therapy" — MHT is for bothersome symptoms, not a universal requirement

- "Hormones will make you look 20 years younger" — while MHT has skin benefits, exaggerated anti-aging claims are not evidence-based

- "You need testosterone pellets for energy and weight loss" — not supported by evidence (see testosterone section below)

- "Saliva testing is the best way to dose hormones" — saliva testing is unreliable and not recommended by any major medical society

- "Compounded hormones are safer because they're 'natural'" — they are unregulated and lack safety data

Trusted resources:

- The Menopause Society (formerly NAMS): menopause.org

- ACOG (American College of Obstetricians and Gynecologists): acog.org

- ISSWSH (International Society for the Study of Women's Sexual Health): isswsh.org

Nonhormonal Options for Women Who Cannot Take MHT

If MHT is not right for you, there are effective alternatives:

Prescription Medications for Hot Flashes:

- Fezolinetant (Veozah) — a newer, non-hormonal medication specifically approved for moderate-to-severe hot flashes; requires liver function monitoring

- Low-dose antidepressants — paroxetine (Brisdelle, the only FDA-approved nonhormonal option for hot flashes), venlafaxine, desvenlafaxine, escitalopram, and citalopram can reduce hot flashes by 40–60%

- Gabapentin — can help with hot flashes and sleep

- Clonidine — modestly effective for hot flashes

- Note: Paroxetine should NOT be used if you are taking tamoxifen

For Vaginal/Urinary Symptoms (GSM):

- Vaginal moisturizers (used regularly) and lubricants (used during intercourse)

- Vaginal DHEA (prasterone/Intrarosa) — a non-estrogen hormonal option

- Ospemifene (Osphena) — an oral non-estrogen option for painful intercourse

Lifestyle Strategies That Help

These approaches can complement MHT or help on their own:

- Regular exercise — improves mood, sleep, bone health, and cardiovascular fitness

- Maintain a healthy weight — excess weight can worsen hot flashes

- Stress management — cognitive behavioral therapy (CBT) and mindfulness-based stress   reduction have evidence for reducing the impact of hot flashes

- Clinical hypnosis — shown in studies to significantly reduce hot flashes

- Dress in layers, keep rooms cool, use fans

- Limit triggers — alcohol, caffeine, spicy foods, and hot beverages can worsen hot flashes

- Prioritize sleep hygiene — consistent schedule, cool bedroom, limit screens before bed

- Calcium and vitamin D — important for bone health (calcium 1,200 mg/day, vitamin D 800–1,000 IU/day from food and supplements)

- Pelvic floor physical therapy — can help with urinary symptoms

What does NOT have good evidence:

Black cohosh, dong quai, evening primrose oil, red clover, ginseng, maca, and omega-3 supplements have not been shown to be more effective than placebo for hot flashes in high-quality studies. Some (like black cohosh) carry risks of liver toxicity.

Testosterone Therapy for Women: What You Should Know

Potential Benefits:

The only evidence-based use of testosterone in women is for the treatment of hypoactive sexual desire disorder (HSDD) — persistent low sexual desire that causes personal distress — in postmenopausal women. When used at doses that keep blood levels in the normal premenopausal range, testosterone can modestly improve sexual desire, arousal, and satisfaction.

Important Limitations:

- There is NO FDA-approved testosterone product for women. When prescribed, it is used "off-label" from male formulations at much lower doses.

- Testosterone is not proven to help with energy, weight loss, muscle building, mood, brain fog, or general well-being in women.

- Data/studies in women is limited.

Side Effects of Testosterone (especially at higher doses):

- Acne

- Increased facial and body hair (hirsutism)

- Oily skin

- Hair thinning on the scalp

- Voice deepening (may be irreversible)

- Clitoromegaly (enlargement — may be irreversible)

- Adverse effects on cholesterol (especially with oral forms)

- Mood swings, irritability, anxiety

- Potential increased risk of cardiovascular events (not well studied)

Why Testosterone Pellets Are Dangerous:

Testosterone pellets are implanted under the skin and dissolve slowly over months. Major medical societies — including NAMS, ISSWSH, the Endocrine Society, and ACOG — recommend AGAINST pellet therapy because:

- Pellets frequently produce supraphysiologic (abnormally high) testosterone levels — often 3–10 times higher than normal

- Once inserted, pellets cannot be removed if levels are too high or side effects develop

- Supraphysiologic testosterone levels can cause: severe acne, significant unwanted hair growth, irreversible voice deepening, hair loss, mood instability and aggression, adverse cholesterol changes, potential cardiovascular harm, abnormal uterine bleeding, and possible increased breast cancer risk

- Pellets are compounded products — not FDA-regulated, with inconsistent dosing and no standardized safety data

- Studies show that 43% of patients discontinue pellet therapy after just one insertion

If testosterone is prescribed, it should be:

- Transdermal (cream or gel) at low doses

- Monitored with blood levels to stay within the normal female range

- Stopped if no benefit is seen within 6 months

What We Monitor to Keep You Safe

Starting MHT is a partnership. Here is what to expect:

Before Starting MHT:

- Thorough medical history and physical exam

- Discussion of your symptoms, health risks, and goals

- Baseline mammogram (if not recent)

Ongoing Monitoring:

- Annual mammograms — essential for all women on MHT

- Cervical cancer screening (Pap smear) — per standard guidelines (every 3–5 years depending on age and test type)

- DEXA scan (bone density) — recommended for women 65+, or earlier if risk factors for osteoporosis are present or to determine baseline prior to starting MHT

- Lipid panel — to monitor cholesterol and triglycerides

- Liver function tests — especially if there is a history of liver disease or if taking certain medications

- Coronary calcium score (CCS) — may be recommended for some women with intermediate cardiovascular risk to help guide MHT decisions

- Blood pressure — checked at regular visits

About Lab Testing:

MHT is primarily dosed based on your symptoms, not blood levels. If you feel well and your symptoms are controlled, labs may not be necessary for dose adjustments. However, in some situations your provider may check:

- Estradiol level — to confirm absorption (especially with transdermal products) or guide dosing

- FSH (follicle-stimulating hormone) — can help confirm menopausal status in perimenopause

- LH (luteinizing hormone) — sometimes checked alongside FSH

- Total testosterone — required before and during testosterone therapy to ensure safe levels

Your provider will reassess your therapy at least annually to make sure the benefits continue to outweigh any risks.

The Bottom Line

Menopause hormone therapy is safe and effective for most healthy women who start it close to menopause. The decision to use MHT — and which type — should be individualized based on your symptoms, health history, and personal preferences. Today's hormone therapy options are very different from what was studied decades ago, and the evidence supports their use when prescribed thoughtfully.